3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
1 min read
20th International Conference on Pharmaceutical Medicine, 19-21st October 2022
SFL, a Veristat company, will participate in a Round table at the 20th International Conference on Pharmaceutical Medicine, at the Stavros Niarchos Foundation Cultural Center, Athens:
We are pleased to announce that Shayesteh Fürst-Ladani, will speak about “How much clinical data from medical device studies is enough to support application for CE Certification? ” in the Roundtable organized from 9:00-10:30 am.
Don’t miss Shayesteh and the full line-up of experts convening to discuss the very latest clinical and regulatory updates.
Chair: Ghazaleh Gouya, Priv. Doz Dr. med Cardiologist, Founder of Gouya insights, GPMed Board Member & IFAPP Board Member
Speakers:
‘Design of clinical MD investigations and approvable endpoints’
Dr. Andreas Beust, Chief Scientific Officer, GCP-Service International Ltd. & Co. KG
‘ How much clinical data from Medical Device studies is enough for CE mark?"
Shayesteh Fürst-Ladani, MBA, MSc, GFMD, Senior Vice President SFL, Head of SFL Group
‘Guidance documents"
Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, School of Medicine, Trinity College
Veristat and SFL, a Veristat company, offer solutions for Pharma and MedTech industry. Featured solutions include strategic and operational support from early development to regulatory approval, market access, quality assurance, pharmacovigilance, and supply chain management, as well as clinical development services including global clinical operations, biostatistics and programming.
Schedule A Meeting
If you would like to meet us at the 20th International Conference on Pharmaceutical 2022, feel free to contact us to arrange a meeting through the form.
Conference Details
Website: https://www.icpm2022.gr/